Does IBRUTINIB Cause Myelodysplastic syndrome? 118 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Myelodysplastic syndrome have been filed in association with IBRUTINIB (Imbruvica). This represents 0.2% of all adverse event reports for IBRUTINIB.
118
Reports of Myelodysplastic syndrome with IBRUTINIB
0.2%
of all IBRUTINIB reports
37
Deaths
28
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From IBRUTINIB?
Of the 118 reports, 37 (31.4%) resulted in death, 28 (23.7%) required hospitalization, and 8 (6.8%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which IBRUTINIB Alternatives Have Lower Myelodysplastic syndrome Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE